Chronic kidney disease and statins: improving cardiovascular outcomes

Related Experiment Video

Updated: Jun 22, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

D Benson Walker1, Thanh Jennifer Walker, Terry A Jacobson

  • 1Office of Health Promotion and Disease Prevention, Emory Faculty Office Building, Atlanta, GA 30303, USA.

Current Atherosclerosis Reports
|June 9, 2009
PubMed

Insights

Statins effectively reduce cardiovascular risks in early chronic kidney disease (CKD). However, they show no benefit in hemodialysis patients, with dose adjustments needed for advanced CKD stages.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Chronic kidney disease (CKD) prevalence is rising globally.
  • CKD patients face higher mortality from cardiovascular events compared to end-stage renal disease.
  • Dyslipidemia is a significant concern in CKD patients, increasing cardiovascular risk.

Purpose of the Study:

  • To review the pathogenesis of dyslipidemia in CKD.
  • To evaluate the role of statins in reducing coronary heart disease (CHD) morbidity and mortality in CKD patients.
  • To discuss statin safety and dosing in various stages of CKD.

Main Methods:

  • Review of major clinical trials involving statins in CKD patients.
  • Analysis of pharmacokinetic and renal excretion differences affecting statin metabolism.
  • Assessment of statin safety profiles across different CKD stages.

Main Results:

  • Statins are effective in reducing cardiovascular events in mild to moderate CKD (Stages I-IV).
  • Dose adjustments for statins are necessary in advanced CKD (Stages III-V) due to altered pharmacokinetics and renal excretion.
  • Two large trials showed no demonstrated clinical benefit of statins in hemodialysis patients.

Conclusions:

  • Statins play a crucial role in managing cardiovascular risk in early to moderate CKD.
  • Careful consideration of dosing and safety is essential for statin use in advanced CKD.
  • Current evidence does not support the use of statins for cardiovascular event reduction in patients undergoing hemodialysis.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...